InvestorsHub Logo
Followers 1
Posts 348
Boards Moderated 0
Alias Born 03/05/2019

Re: None

Friday, 05/17/2019 12:30:16 AM

Friday, May 17, 2019 12:30:16 AM

Post# of 233145
CYDY is working towards a mechanism of action approval that would allow it to be used on any metastatic cancer expressing CCR5 something like Keytruda.
That is why animal pre-clinical studies are ongoing for another 8 cancers.
CYDY patent covers about 200 different types of cancer.
This is not just about mTNBC, the story is much wider and more serious, RP has a clear goal and therefore came to CYDY.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News